JPH11511856A - 血液検査の実施方法 - Google Patents
血液検査の実施方法Info
- Publication number
- JPH11511856A JPH11511856A JP9540286A JP54028697A JPH11511856A JP H11511856 A JPH11511856 A JP H11511856A JP 9540286 A JP9540286 A JP 9540286A JP 54028697 A JP54028697 A JP 54028697A JP H11511856 A JPH11511856 A JP H11511856A
- Authority
- JP
- Japan
- Prior art keywords
- blood
- hirudin
- thrombin inhibitor
- measurement
- clinical chemistry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/108331—Preservative, buffer, anticoagulant or diluent
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 新鮮に採取した血液試料を、少なくとも1種のトロンビン阻害剤と混合 し、かつ上記血液試料を臨床化学的指標および血液学的指標の両方の測定に使用 することを特徴とする、血液検査の実施方法。 2. トロンビン阻害剤としてヒルジンおよび/またはデスルファトヒルジン を使用することを特徴とする、請求項1記載の方法。 3. 組換えヒルジンおよび/またはデスルフアトヒルジンを使用することを 特徴とする、請求項2記載の方法。 4. 臨床化学的指標の測定に先立ち、血液試料から細胞性および血球成分を 除去することを特徴とする、請求項1から3いずれか1項記載の方法。 5. 血球算定および/または鑑別血球算定を実施することを特徴とする、請 求項1から3のいずれか1項記載の方法。 6. 血液型試験、抗体スクリーニング検査、クームス試験または赤血球濃縮 物を用いる検査を実施することを特徴とする、請求項1から3のいずれか1項記 載の方法。 7. 末梢血または骨髄血を用いて免疫表現型タイピング操作を実施すること を特徴とする、請求項1から3のいずれか1項記載の方法。 8. 新鮮に採取した血液試料をトロンビン阻害剤含有容器中に入れることを 特徴とする、請求項1から7のいずれか1項記載の方法。 9. 測定操作を自動測定装置で実施することを特徴とする、請求項1から7 のいずれか1項記載の方法。 10. 新鮮に採血した血液試料を少なくとも一種のトロンビン阻害剤と混合 し、得られた血液試料を用いて臨床化学的指標を測定することを特徴とする、臨 床化学的血液指標の測定方法。 11. 細胞性および血球成分を、臨床化学的指標測定に先立ち血液試料から 除去することを特徴とする、請求項10記載の方法。 12. ヒルジンおよび/またはデスルフアトヒルジンをトロンビン阻害剤と して使用することを特徴とする、請求項10または11記載の方法。 13. 組換えヒルジンおよび/またはデスルフアトヒルジンを使用すること を特徴とする、請求項12記載の方法。 14. 新鮮に採取した血液試料をトロンビン阻害剤含有容器中に入れること を特徴とする、請求項10から13のいずれか1項記載の方法。 15. 測定操作を自動測定装置により実施することを特徴とする、請求項1 0から13のいずれか1項記載の方法。 16. 臨床化学的血液指標を血漿を用いて測定することを特徴とする、請求 項10から15のいずれか1項記載の方法。 17. 臨床化学的指標および血液学的指標両方を測定するための、少なくと も1種のトロンビン阻害剤を含む採血容器の使用。 18. 臨床化学的指標を測定するための、少なくとも1種のトロンビン阻害 剤を含む採血容器の使用。 19. トロンビン阻害剤がヒルジンおよび/またはデスルフアトヒルジンで あることを特徴とする、請求項17または18記載の使用。 20. トロンビン阻害剤が組換えヒルジンおよび/またはデスルフアトヒル ジンであることを特徴とする、請求項18記載の使用。 21. 採血容器が少なくとも1種のトロンビン阻害剤で被覆されていること を特徴とする、請求項17から20のいずれか1項記載の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19620443A DE19620443C2 (de) | 1996-05-21 | 1996-05-21 | Verfahren zum automatischen Durchführen von Bluttests |
DE19620443.7 | 1996-05-21 | ||
PCT/EP1997/002343 WO1997044661A1 (de) | 1996-05-21 | 1997-05-07 | Verfahren zum durchführen von bluttests |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH11511856A true JPH11511856A (ja) | 1999-10-12 |
JP3523883B2 JP3523883B2 (ja) | 2004-04-26 |
Family
ID=7794907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54028697A Expired - Fee Related JP3523883B2 (ja) | 1996-05-21 | 1997-05-07 | 血液検査の実施方法 |
Country Status (10)
Country | Link |
---|---|
US (1) | US6521460B1 (ja) |
EP (1) | EP0912891B1 (ja) |
JP (1) | JP3523883B2 (ja) |
AT (1) | ATE226322T1 (ja) |
AU (1) | AU2893697A (ja) |
DE (2) | DE19620443C2 (ja) |
DK (1) | DK0912891T3 (ja) |
ES (1) | ES2185937T3 (ja) |
PT (1) | PT912891E (ja) |
WO (1) | WO1997044661A1 (ja) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19835721A1 (de) * | 1998-08-07 | 2000-02-10 | Edi Experimentelle & Diagnosti | Verfahren zur Bestimmung der Immunabwehr des Blutes sowie Testkit hierfür und Verwendung eines geeigneten Spritzenzylinders |
US20060030758A1 (en) * | 2004-08-09 | 2006-02-09 | Francotyp-Postalia Ag & Co. Kg | Mypersonallab |
CN102778378A (zh) * | 2012-08-07 | 2012-11-14 | 天津市百利康泰生物技术有限公司 | 一种含水蛭素的抗凝载玻片及其制备方法 |
EP4098239A1 (en) * | 2012-09-06 | 2022-12-07 | Labrador Diagnostics LLC | Systems, devices, and methods for bodily fluid sample collection |
US9636062B2 (en) * | 2012-09-06 | 2017-05-02 | Theranos, Inc. | Systems, devices, and methods for bodily fluid sample collection |
US9427184B2 (en) * | 2012-09-06 | 2016-08-30 | Theranos, Inc. | Systems, devices, and methods for bodily fluid sample collection |
US10248765B1 (en) | 2012-12-05 | 2019-04-02 | Theranos Ip Company, Llc | Systems, devices, and methods for bodily fluid sample collection, transport, and handling |
US9386948B2 (en) | 2012-12-05 | 2016-07-12 | Theranos, Inc. | Systems, devices, and methods for bodily fluid sample transport |
KR20150133774A (ko) | 2013-03-15 | 2015-11-30 | 테라노스, 인코포레이티드 | 시료 수집 및 시료 분리용 방법과 기기 |
WO2015138818A1 (en) | 2014-03-12 | 2015-09-17 | Theranos, Inc. | Systems, devices, and methods for bodily fluid sample collection |
US10371606B2 (en) | 2015-07-21 | 2019-08-06 | Theraos IP Company, LLC | Bodily fluid sample collection and transport |
US11247208B2 (en) | 2015-09-09 | 2022-02-15 | Labrador Diagnostics Llc | Methods and devices for sample collection and sample separation |
US11857966B1 (en) | 2017-03-15 | 2024-01-02 | Labrador Diagnostics Llc | Methods and devices for sample collection and sample separation |
CN108152177B (zh) * | 2017-12-11 | 2020-11-24 | 三诺生物传感股份有限公司 | 一种快速检测血细胞压积的方法 |
GB202018286D0 (en) * | 2020-11-20 | 2021-01-06 | Randox Laboratories Ltd | Methods for use in preventative healthcare |
CN113341163B (zh) * | 2021-06-03 | 2024-01-19 | 上海市血液中心 | 一种-d-稀有血型筛选试剂及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5372933A (en) | 1988-10-03 | 1994-12-13 | The Scripps Research Institute | Polypeptides that mimic receptor-induced binding sites, and methods of using same |
DE59109048D1 (de) * | 1990-02-14 | 1998-10-15 | Pentapharm Ag | Inhibitoren zur antikoagulierenden Vorbehandung von Blutproben |
JP2965359B2 (ja) * | 1991-01-07 | 1999-10-18 | 積水化学工業株式会社 | 血液検査用容器 |
DE4329969A1 (de) * | 1993-09-04 | 1995-03-09 | Basf Ag | Verfahren zur rekombinanten Herstellung von Proteinen in Hefe |
US5763199A (en) * | 1994-09-29 | 1998-06-09 | Mount Sinai School Of Medicine Of The City University Of New York | Platelet blockade assay |
-
1996
- 1996-05-21 DE DE19620443A patent/DE19620443C2/de not_active Expired - Fee Related
-
1997
- 1997-05-07 AT AT97923007T patent/ATE226322T1/de not_active IP Right Cessation
- 1997-05-07 WO PCT/EP1997/002343 patent/WO1997044661A1/de active IP Right Grant
- 1997-05-07 EP EP97923007A patent/EP0912891B1/de not_active Expired - Lifetime
- 1997-05-07 US US09/180,806 patent/US6521460B1/en not_active Expired - Fee Related
- 1997-05-07 ES ES97923007T patent/ES2185937T3/es not_active Expired - Lifetime
- 1997-05-07 PT PT97923007T patent/PT912891E/pt unknown
- 1997-05-07 DE DE59708506T patent/DE59708506D1/de not_active Expired - Lifetime
- 1997-05-07 AU AU28936/97A patent/AU2893697A/en not_active Abandoned
- 1997-05-07 DK DK97923007T patent/DK0912891T3/da active
- 1997-05-07 JP JP54028697A patent/JP3523883B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE59708506D1 (de) | 2002-11-21 |
AU2893697A (en) | 1997-12-09 |
DE19620443A1 (de) | 1997-11-27 |
PT912891E (pt) | 2003-03-31 |
DE19620443C2 (de) | 1998-09-17 |
JP3523883B2 (ja) | 2004-04-26 |
US6521460B1 (en) | 2003-02-18 |
EP0912891B1 (de) | 2002-10-16 |
DK0912891T3 (da) | 2003-02-24 |
ES2185937T3 (es) | 2003-05-01 |
ATE226322T1 (de) | 2002-11-15 |
WO1997044661A1 (de) | 1997-11-27 |
EP0912891A1 (de) | 1999-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH11511856A (ja) | 血液検査の実施方法 | |
Garratty et al. | Correlation between in vivo hemolysis and the amount of red cell‐bound IgG measured by flow cytometry | |
JP3075751B2 (ja) | 血液試料の抗凝血剤前処理のためのインヒビター | |
Zuzel et al. | A method for measuring plasma ristocetin cofactor activity—normal distribution and stability during storage | |
Rebulla et al. | Multicenter evaluation of methods for counting residual white cells in leukocyte-depleted red blood cells | |
Terčič et al. | The basis of the synovial fluid analysis | |
Landt et al. | Interference in ionized calcium measurements by heparin salts | |
Kasperek et al. | Concentration differences between serum and plasma of the elements cobalt, iron, mercury, rubidium, selenium and zinc determined by neutron activation analysis | |
JP3759512B2 (ja) | 脳脊髄液などの体液試料をアッセイするための自動法およびそのための試薬 | |
US6444471B1 (en) | Reticulocyte containing complete blood control | |
Beheshti et al. | EDTA-plasma vs serum differences in cholesterol, high-density-lipoprotein cholesterol, and triglyceride as measured by several methods | |
JPS6360862B2 (ja) | ||
Udden et al. | Decreased deform ability of erythrocytes and increased intracellular calcium in patients with chronic renal failure | |
Stephen et al. | Analytical comparison between microhematocrit and automated methods for packed cell volume (PCV) determination | |
JP3713901B2 (ja) | 破骨細胞由来酸性ホスファターゼの測定方法 | |
Walter et al. | Differential electrophoretic behavior in aqueous polymer solutions of red blood cells from Alzheimer patients and from normal individuals | |
Clark et al. | Routine and point-of-care testing in hematology: Manual and semiautomated methods | |
Donnelly et al. | Is heparinized plasma suitable for use in routine biochemistry? | |
Werman et al. | White blood cell count and differential count | |
Grette | The release of 5-hydroxytryptamine (serotonin) from blood platelets during coagulation | |
Kubiak et al. | The diagnostic pitfalls and challenges associated with basic hematological tests | |
RU2762820C1 (ru) | Способ функциональной и количественной оценки тромбоцитарно-моноцитарных комплексов в образцах цельной периферической крови | |
Alamin | Comparison of Plasma Fibrinogen Level and Complete Blood Count among Glycomic Control Diabetic Mellitus Patients Type 2 in Shendi Town | |
Tsuji et al. | Tissue factor pathway inhibitor as a universal anticoagulant for use in clinical laboratory tests | |
Radwan et al. | HEMATOLOGICAL REFERENCE VALUES FOR HEALTHY ADULTS IN EGYPT |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040210 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080220 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090220 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090220 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100220 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110220 Year of fee payment: 7 |
|
LAPS | Cancellation because of no payment of annual fees |